Skip to main content
Fig. 3 | BMC Medical Imaging

Fig. 3

From: Application value of the treatment of breast cancer bone metastases with radioactive seed 125I implantation under CT-guidance

Fig. 3

Comparison of CA125 levels between the two groups \(\left( {{\overline{\text{x}}} \pm {\text{s}}} \right)\). Note: The abscissa represents the experimental group and the control group after treatment, and the ordinate represents the level of CA125, (U/mL); The level of CA125 in the experimental group after treatment was (11.93 ± 3.78) U/mL; The level of CA125 in the control group after treatment was (15.78 ± 4.12) U/mL); *Indicated significant difference in the level of CA125 between the two groups after treatment (t = 4.619, P = 0.000)

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us